BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rihawi K, Ricci AD, Rizzo A, Brocchi S, Marasco G, Pastore LV, Llimpe FLR, Golfieri R, Renzulli M. Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications. Int J Mol Sci 2021;22:3805. [PMID: 33916915 DOI: 10.3390/ijms22083805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Yao L, Qu J, Liu L, Lu N, Wang J, Zhang J. Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression. J Transl Med 2021;19:325. [PMID: 34332586 DOI: 10.1186/s12967-021-03012-z] [Reference Citation Analysis]
2 Yeh JH, Yeh YS, Tsai HL, Huang CW, Chang TK, Su WC, Wang JY. Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at? Cancers (Basel) 2022;14:3026. [PMID: 35740693 DOI: 10.3390/cancers14123026] [Reference Citation Analysis]
3 Liu Z, Liang Y, Tang X, Qu H. Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer. Front Surg 2021;8:745748. [PMID: 34869556 DOI: 10.3389/fsurg.2021.745748] [Reference Citation Analysis]
4 Yang Y, Yang Y, Chen M, Chen J, Wang J, Ma Y, Qian H. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages. Biomater Sci 2021;9:6597-608. [PMID: 34582523 DOI: 10.1039/d1bm01053k] [Reference Citation Analysis]
5 Ieni A, Caruso RA, Pizzimenti C, Giuffrè G, Irato E, Rigoli L, Navarra G, Fadda G, Tuccari G. M1 Polarized Tumor-Associated Macrophages (TAMs) as Promising Prognostic Signature in Stage I–II Gastric Adenocarcinomas. GastrointestDisord 2021;3:207-17. [DOI: 10.3390/gidisord3040020] [Reference Citation Analysis]
6 Albracht SP. Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto. Cancer Treatment and Research Communications 2022. [DOI: 10.1016/j.ctarc.2022.100537] [Reference Citation Analysis]
7 Ucaryilmaz Metin C, Ozcan G. The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer. Cancers (Basel) 2022;14:2711. [PMID: 35681691 DOI: 10.3390/cancers14112711] [Reference Citation Analysis]
8 Xu B, Chen F, Zhang X, Wang Z, Che K, Wu N, Yu L, Fan X, Liu B, Wei J. Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer. Cancers 2022;14:2758. [DOI: 10.3390/cancers14112758] [Reference Citation Analysis]
9 Kalfon T, Loewenstein S, Gerstenhaber F, Leibou S, Geller H, Sher O, Nizri E, Lahat G. Gastric Cancer-Derived Extracellular Vesicles (EVs) Promote Angiogenesis via Angiopoietin-2. Cancers (Basel) 2022;14:2953. [PMID: 35740619 DOI: 10.3390/cancers14122953] [Reference Citation Analysis]